Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tan, Jack Wei Chieh | - |
dc.contributor.author | Sim, David | - |
dc.contributor.author | Ako, Junya | - |
dc.contributor.author | Almahmeed, Wael | - |
dc.contributor.author | Cooper, Mark E. | - |
dc.contributor.author | Dalal, Jamshed J. | - |
dc.contributor.author | Deerochanawong, Chaicharn | - |
dc.contributor.author | Huang, David Wei Chun | - |
dc.contributor.author | Johar, Sofian | - |
dc.contributor.author | Kaul, Upendra | - |
dc.contributor.author | Kim, Sin Gon | - |
dc.contributor.author | Koh, Natalie | - |
dc.contributor.author | Kong, Alice Pik-Shan | - |
dc.contributor.author | Krittayaphong, Rungroj | - |
dc.contributor.author | Kwok, Bernard | - |
dc.contributor.author | Matawaran, Bien J. | - |
dc.contributor.author | Quang Ngoc Nguyen | - |
dc.contributor.author | Ong, Loke Meng | - |
dc.contributor.author | Park, Jin Joo | - |
dc.contributor.author | Peng, Yongde | - |
dc.contributor.author | Quek, David K. L. | - |
dc.contributor.author | Suastika, Ketut | - |
dc.contributor.author | Sukor, Norlela | - |
dc.contributor.author | Teo, Boon Wee | - |
dc.contributor.author | Teoh, Chee Kiang | - |
dc.contributor.author | Zhang, Jian | - |
dc.contributor.author | Reyes, Eugenio B. | - |
dc.contributor.author | Goh, Su Yen | - |
dc.date.accessioned | 2021-06-24T06:40:41Z | - |
dc.date.available | 2021-06-24T06:40:41Z | - |
dc.date.issued | 2021-03 | - |
dc.identifier.issn | 1758-3756 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/53372 | - |
dc.description.abstract | The Asian Pacific Society of Cardiology convened a consensus statement panel for optimising cardiovascular (CV) outcomes in type 2 diabetes, and reviewed the current literature. Relevant articles were appraised using the Grading of Recommendations, Assessment, Development and Evaluation system, and consensus statements were developed in two meetings and were confirmed through online voting. The consensus statements indicated that lifestyle interventions must be emphasised for patients with prediabetes, and optimal glucose control should be encouraged when possible. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are recommended for patients with chronic kidney disease with adequate renal function, and for patients with heart failure with reduced ejection fraction. In addition to SGLT2i, glucagon-like peptide-1 receptor agonists are recommended for patients at high risk of CV events. A blood pressure target below 140/90 mmHg is generally recommended for patients with type 2 diabetes. Antiplatelet therapy is recommended for secondary prevention in patients with atherosclerotic CV disease. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | RADCLIFFE CARDIOLOGY | - |
dc.title | Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.15420/ecr.2020.52 | - |
dc.identifier.scopusid | 2-s2.0-85105579149 | - |
dc.identifier.wosid | 000653034400014 | - |
dc.identifier.bibliographicCitation | EUROPEAN CARDIOLOGY REVIEW, v.16 | - |
dc.citation.title | EUROPEAN CARDIOLOGY REVIEW | - |
dc.citation.volume | 16 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | LIFE-STYLE INTERVENTION | - |
dc.subject.keywordPlus | BLOOD-PRESSURE CONTROL | - |
dc.subject.keywordPlus | FOLLOW-UP | - |
dc.subject.keywordPlus | GLUCOSE CONTROL | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordAuthor | Type 2 diabetes | - |
dc.subject.keywordAuthor | cardiovascular | - |
dc.subject.keywordAuthor | sodium-glucose cotransporter 2 inhibitor | - |
dc.subject.keywordAuthor | glucagon-like protein 1 receptor agonist | - |
dc.subject.keywordAuthor | consensus | - |
dc.subject.keywordAuthor | Asia Pacific | - |
dc.subject.keywordAuthor | prediabetes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.